The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI’s priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
[Link to provocative questions: https://provocativequestions.nci.nih.gov/pq-funding-opportunity-information/current-rfas-and-pqs ]
There are two funding opportunities to address these questions currently open that may be of interest to you. One is a large (R01) grant (clinical trials are allowed in this grant) and the other is an exploratory/developmental grant (R21) that is smaller and earlier stage.
- Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R01 Clinical Trial Optional) https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-019.html
- Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trials Optional) https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-020.html
Even if you are not going to apply, it is worthwhile reading the provocative questions. They provide insight into what NCI thinks are important areas of research.
Open Date (Earliest Submission Date): May 29, 2018
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): June 29, 2018, October 30, 2018), by 5:00 PM local time of applicant organisation.
